Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes

In patients with type 2 diabetes and chronic kidney disease, weekly semaglutide significantly reduced risks of major kidney events, cardiovascular events, and death from any cause while slowing loss of kidney function.

​   The New England Journal of Medicine: Search Results in Endocrinology